All dossiers
gi.acute-cholangitis.core.v1
Acute Cholangitis
gastroenterologyacuteadultacuteinpatient
Manifest is a batch23 SCAFFOLD only (defineBatch23ScaffoldManifest with single sourceWorkupId acute_cholangitis); no phenotypes/red-flags/medications/dosing authored. Problem-package at src/lib/tier3/problem-package/packages/acute-cholangitis/ exists with full atom set, but no `_design-brief.md` and the engine-side manifest is a stub. Workup `acute_cholangitis` is registered in clinical-tools-registry (TG18). No engine-specific calculators; calc.qsofa borrowed for sepsis screen. Gaps: full evidence reconciliation needed (TG18 + ACG cholangitis); empty terminology arrays (codes live in workup adapter); regimen_axes empty (pip-tazo, ceftriaxone+metronidazole, meropenem need RxCUI verification); no design brief; no dedicated test_files.
Entry points (4)
- symptomCharcot triad — fever + RUQ pain + jaundice (ACG 2024)charcot_triad
- symptomReynolds pentad — Charcot + AMS + shock (ACG 2024)reynolds_pentad
- lab_abnormalityCholestatic LFTs (ALP/GGT/bilirubin elevated) (ACG 2024)cholestatic_lfts
- imagingCBD dilation / choledocholithiasis on imaging (ACG 2024)cbd_dilation
Required inputs (12)
- agerequireddemographic • used at CONTEXTTG18 severity adjusts thresholds; geriatric mortality risk (ACG 2024)
- temperaturerequiredvital • used at CONTEXTFever/chills core to Charcot triad (ACG 2024)
- sbprequiredvital • used at CONTEXTHypotension defines TG18 Grade III; sepsis screen (ACG 2024)
- hrrequiredvital • used at CONTEXTTachycardia for SIRS/sepsis (ACG 2024)
- wbcrequiredlab • used at INITIAL_WORKUPLeukocytosis + organ dysfunction stratifies TG18 grade (ACG 2024)
- total_bilirubinrequiredlab • used at INITIAL_WORKUPCholestatic injury marker; TG18 diagnostic component (ACG 2024)
- alprequiredlab • used at INITIAL_WORKUPCholestatic pattern confirmation (ACG 2024)
- creatininerequiredlab • used at INITIAL_WORKUPRenal organ dysfunction (TG18 III); contrast/abx dosing (ACG 2024)
- lactatelab • used at RED_FLAGSSeverity marker — sepsis / hypoperfusion (ACG 2024)
- ruq_usrequiredimaging • used at INITIAL_WORKUPFirst-line — CBD dilation, stones (ACG 2024)
- mrcpimaging • used at BRANCHING_WORKUPNon-invasive ductal anatomy when US equivocal (ACG 2024)
- prior_biliary_surgeryhistory • used at CONTEXTAnatomy alters ERCP feasibility (ACG 2024)
12-phase flow (12)
- 1FRAMEConfirm acute biliary sepsis scope; differentiate from acute cholecystitis without ductal obstruction (ACG 2024)inputs: ageadvance: biliary obstruction + infection plausible
- 2ENTRYRecognize Charcot/Reynolds pentad or cholestatic LFT abnormality (ACG 2024)advance: one entry trigger present
- 3CONTEXTVitals, prior biliary surgery, anticoagulation, comorbidities, allergies (ACG 2024)inputs: temperature, sbp, hr, prior_biliary_surgeryadvance: context captured
- 4RED_FLAGSReynolds pentad (shock + AMS), TG18 Grade III organ dysfunction, suppurative cholangitis (ACG 2024)inputs: sbp, lactateactions: calc.qsofaadvance: shock identified or excluded
- 5INITIAL_WORKUPCBC, LFT (ALP/bilirubin/GGT/AST/ALT), BMP, lactate, blood cultures x2, RUQ ultrasound (ACG 2024)inputs: wbc, total_bilirubin, alp, creatinine, ruq_usactions: panel.lft, panel.cbc, panel.renaladvance: labs + US obtained
- 6BRANCHING_WORKUPMRCP if US non-diagnostic; CT if abscess/perforation; EUS for distal CBD stones (ACG 2024)inputs: mrcpactions: acute_cholangitisadvance: biliary obstruction characterised
- 7DIFFERENTIALConfirm cholangitis vs acute cholecystitis, hepatic abscess, viral hepatitis, pancreatitis (ACG 2024)advance: differential resolved
- 8RISK_STRATIFICATIONTG18 severity grade I / II / III; sepsis screen (ACG 2024)inputs: wbc, creatinineactions: calc.qsofaadvance: TG18 grade assigned
- 9TREATMENTEmpiric IV antibiotics + biliary drainage (ERCP first-line; PTBD if ERCP not feasible) within 24h for moderate-severe (ACG 2024)inputs: creatinineadvance: antibiotics started + drainage plan in motion
- 10DISPOSITIONICU for Grade III; floor for Grade I-II; ERCP/IR scheduling (ACG 2024)inputs: sbpadvance: destination + procedure timing locked
- 11MONITORINGSerial vitals, daily LFT trend, lactate clearance, response to drainage (ACG 2024)inputs: total_bilirubin, lactateadvance: response documented or escalated
- 12FOLLOWUPInterval cholecystectomy after stone-related cholangitis; LFT normalization; recurrence counseling (ACG 2024)advance: follow-up scheduled